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ORIGINAL ARTICLEValidation of the English Language
Pain Sensitivity QuestionnaireAlethia Baldwin Sellers, MD,* Ruth Ruscheweyh, MD,† Bernard Joseph Kelley, MD,‡
Timothy J. Ness, MD, PhD,* and Thomas R. Vetter, MD, MPH*Background and Objectives: The Pain Sensitivity Questionnaire
(PSQ) is predictive of pain-related responses to experimental stimuli
in German-speaking individuals. Here, we explored the validation of
the English translation of the PSQ (PSQ-E).
Methods: One hundred thirty-six patients scheduled to undergo a low
back interventional procedure completed the PSQ-E and other ques-
tionnaires including the Brief Pain Inventory. Pain ratings on a visual an-
alog scale (VAS) were obtained following 2 standardized injections of
subcutaneous lidocaine (VAS 1, infiltration in hand; VAS 2, infiltration
of procedural site). The VAS measures were compared with the PSQ-E
data and other inventories using linear regression analysis with stepwise
selection of variables.
Results: The PSQ-E properties were in all respects similar to those
of the original German PSQ. VAS 1 magnitude was predicted by PSQ-
E-minor (r = 0.26, P < 0.01). VAS 2 magnitude was predicted by
PSQ-E-minor (r = 0.34, P < 0.001), and the prediction was significantly
enhanced by further inclusion of the Brief Pain Inventory interference
score (total r = 0.40, P < 0.001).
Conclusions: The study demonstrated that a significant correlation
exists between the PSQ-E and clinically relevant pain ratings. This study
validates the PSQ-E both in terms of measuring pain sensitivity and as
possible means of recognizing patients with high pain sensitivity. Defin-
ing this subset of patients may have clinical utility in the future.
(Reg Anesth Pain Med 2013;38: 508–514)
Chronic pain patients often undergo interventional proceduresas a part of their treatment. Many biopsychosocial factors
contribute to the pain experienced by a patient during and after
such an interventional procedure.1–3 Patients’ innate pain sen-
sitivity is one factor likely to influence their perception of
procedure-related pain.4,5 Presently, there are a limited number
of validated tools to assess this factor before the performance
of a procedure.
Experimental determination of innate pain sensitivity us-
ing quantitative sensory testing techniques is of interest be-
cause of clinical applications in predicting procedural pain and
treatment response.4,5 Preoperative experimental pain sensi-
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Copyright © 2013 American Society of Regional Anesthesia and Painexperimental pain sensitivity has been observed in numerous
chronic pain disorders including low back pain.7 Stimuli of differ-
ent types (thermal, mechanical, ischemic, or electrical) have been
applied in the experimental assessment of pain sensitivity.8 Un-
fortunately, the utility of such methodologies is limited by a
number of factors, including the need for specialized equipment;
increased staffing time and costs; and the aversive experience
for the tested participants.9 The Pain Sensitivity Questionnaire
(PSQ) was developed as a clinically useful, valid self-rating mea-
sure of pain sensitivity without these limitations. The PSQ has
been demonstrated to provide information similar to experimen-
tally derived pain sensitivity assessments.9 Specifically, the PSQ
scores have been shown in a German cohort to correlate signifi-
cantly with a variety of experimentally produced pain intensity
ratings, both in healthy participants and chronic pain patients.9,10
The PSQ has yet to be studied in a native English-speaking pop-
ulation or applied in a clinical pain management setting.
Innate pain sensitivity may affect the need for intravenous
(IV) sedatives and analgesics during an interventional pain pro-
cedure and the response to the pain treatment intervention.
There is also an experimental finding that chronic pain patients
who exhibit high pain sensitivity respond less well to treatment
than those with lower pain sensitivity.11,12 The greater procedural
pain perceived by some patients may contribute to overall treat-
ment failure by reducing their willingness to participate in addi-
tional interventions. Thus, if patients have a high level of innate
pain sensitivity, successful interventional pain treatment may
require procedural sedation and analgesia. The PSQ is a low-
respondent-burden instrument that may help identify patients
who are highly sensitive.
Because the English version of the PSQ (PSQ-E) (Supple-
mental Digital Content 1, http://links.lww.com/AAP/A94) may
have clinical utility in the future, this study was undertaken in
a clinical pain management setting to validate the questionnaire
in an adult chronic pain population.METHODS
Setting and Participants
This study was conducted in an outpatient chronic pain
medicine clinic between May 2010 and July 2011. This study
was approved by the institutional review board of the University
of Alabama at Birmingham and abided by the Ethical Principles
for Medical Research Involving Human Subjects outlined in
the Declaration of Helsinki. Written patient consent and autho-
rization of use of protected health information were obtained
before study enrollment. Study participation was offered to adult
chronic low back pain patients (having pain for greater than
3 months) who were scheduled to receive a lumbar epidural ste-
roid injection (LESI), lumbar facet joint injection (LFJI), or
sacroiliac joint injection (SIJI). Exclusion criteria included
failed back surgery syndrome (postlaminectomy syndrome,
lumbar region, International Classification of Diseases, NinthMedicine • Volume 38, Number 6, November-December 2013
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a non-English speaker, allergy to an amide local anesthetic, and
history of a seizure disorder, diabetic neuropathy, substance abuse
disorder, or major psychiatric disorder (eg, severe depression,
bipolar disorder, Axis II personality disorder, and schizo-
phrenia). In addition, only white subjects were included in
the present study for improved comparability with existing
data collected with the German version of the PSQ. All sub-
jects reported to be English speakers born in the United States.
A parallel study examined the effects of ethnic/cultural dif-
ferences on these measures.
Study Design
This observational study was prospective and single arm
in design. On the day on which participants were to undergo
their interventional pain procedure, each completed the Brief
Pain Inventory-Short Form (BPI-SF), Roland-Morris Back Pain
Questionnaire (RMQ), Hospital Anxiety and Depression Scale
(HADS), Pain Catastrophizing Scale (PCS), and PSQ. Patient
age, sex, race, primary chronic pain-related diagnosis, duration
of chronic pain symptoms, and chronic opioid and nonopioid




The visual analog scale (VAS) for pain intensity has been
widely applied in pain management and clinical research13,14
The VAS used was a horizontal 100-mm line, anchored by ver-
bal descriptors “no pain” (pain score of 0) and “worst pain”
(pain score of 100), along which patients were asked to record
their pain intensity.
Brief Pain Inventory-Short Form
The BPI-SF is a self-administered questionnaire that
assesses the severity of pain and the impact of pain on daily
function (ie, functional disability),15 using an 11-point numeri-
cal rating scale with anchors of “no pain” and “pain as bad as
you can imagine.” The BPI-SF also measures how much pain
has interfered with 7 daily activities in the last 24 hours, specif-
ically, general activity, walking, work, mood, enjoyment of life,
relations with others, and sleep.15 Respondents rate each activ-
ity on an 11-point scale (from 0, “does not interfere” to 10,
“completely interferes”). The BPI-SF pain interference value
was scored here as typically the mean of the 7 interference
items, with a scoring range of 0 to 10.
Roland-Morris Back Pain Questionnaire
The RMQ was created by selecting 24 pain and function
items from the Sickness Impact Profile considered to be relevant
to chronic low back pain.16–18
Hospital Anxiety and Depression Scale
The HADS has been widely applied in inpatient and outpa-
tient health care settings to detect symptoms of anxiety and de-
pression in nonpsychiatric patients.19
Pain Catastrophizing Scale
The PCS validly and reliably assesses the construct of
pain catastrophizing. For research analysis purposes, a study
participant’s PCS score can be used as a confounding covariate
and/or a primary or secondary outcome measure.20© 2013 American Society of Regional Anesthesia and Pain Medicine
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The PSQ is a low-respondent burden, patient self-completed,
pencil-and-paper instrument for the assessment of pain sensitiv-
ity and is intended to provide information similar to experimen-
tally derived pain sensitivity assessment.9 Comprising 17 items
(rated from 0, not at all painful to 10, most severe pain imagin-
able) and requiring 5 to 10 minutes to complete, the PSQ is
based on pain-intensity ratings of daily life situations. Three
items describe situations that are normally not rated as painful
by healthy individuals (eg, taking a warm shower) and do not
form part of the final score. In addition to a PSQ total score, a
PSQ minor score and a PSQ moderate score are generated.9
These 2 subscores were identified in the previous study9 by
factor analysis, each including 7 items that on average were
rated as moderately painful (mean rating of 4–6 on the 11-
point-scale, PSQ-moderate) or as causing minor pain (mean rat-
ing of < 4, PSQ-minor). The PSQ-total score was calculated as
the average rating of items 1, 2, 3, 4, 6, 7, 8, 10, 11, 12, 14, 15,
16, and 17 (all but the 3 nonpainful items), the PSQ-minor score
was calculated as the average rating of items 3, 6, 7, 10, 11, 12,
and 14 and the PSQ-moderate score was calculated as the aver-
age rating of items 1, 2, 3, 8, 15, 16, and 17.9 The original
German version of the PSQ has been shown in a German cohort
to be significantly correlated to a variety of experimentally pro-
duced pain intensity ratings, both in healthy controls and in
chronic pain patients.9,10 The previously published English
translation of the PSQ (PSQ-E) was used in the present study.9
This translation was performed according to the guidelines for
cross-cultural adaptation of self-report measures.21 Two bilin-
gual, native English speakers independently translated the orig-
inal German version of PSQ. The 2 translated versions and the
original version were compared and discussed by the translators
until consensus was reached. Then, back translation was per-
formed by 2 independent bilingual, native German speakers,
both professional translators who were unaware of the purpose
of translation. The back translation was compared with the
original German version and discussed by an expert committee
comprised of all 4 translators, the developer, a psychologist
with experience in questionnaire design and cross-cultural ad-
aptation, and several health care professionals until reaching
consensus.
Lidocaine as Experimental Pain Stimulus
The present study used the injection of subcutaneous lido-
caine as a controllable, clinically relevant noxious stimulus in
a fashion similar to previous clinical studies.22–26 The sensations
evoked by a subcutaneous lidocaine stimulus have sufficient re-
producibility to allow for statistical comparison between alternate
treatment groups and to demonstrate differences with relatively
small numbers of subjects.27–29 Most pertinent to our study, the
subcutaneous infiltration of lidocaine has been used as a stan-
dardized experimental pain stimulus to assess hyperalgesia30
and verbal and behavioral pain responses31 in patients under-
going interventional pain treatment procedures for chronic low
back pain. A recent report suggests this may be useful even as
a predictor of outcomes.32
Study Protocol
After informed consent and completion of questionnaires,
patients had an IV catheter placed in the dorsum of their hand.
Before IV placement, patients received 1 mL of nonbuffered,
plain 1% lidocaine as a subcutaneous local anesthetic using a
25-gauge hypodermic needle. Each participant then immedi-
ately rated the pain associated with this injection (VAS 1) before509
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the prone position on a fluoroscopic procedure table. Fluoro-
scopic guidance was used to identify the site of the injection.
A skin wheal was created there with another 1 mL of non-
buffered, plain 1% lidocaine delivered via a 25-gauge hypoder-
mic needle, and participants were asked immediately to rate
the pain associated with the second injection (VAS 2). Patients
then received 2 mg of IV midazolam, 8 mL of buffered, plain
1% lidocaine, via a 22-gauge hypodermic needle, into the deeper
soft and ligamentous tissues at the site of their LESI, LFJI, or
SIJI, and the procedure was performed. During the LESI, an
18-gauge 3.5-in Touhy needle was advanced under antero-
posterior (AP) and lateral fluoroscopy using the loss of resis-
tance technique. One milliliter of contrast was injected in the
lateral and AP position to confirm epidural contrast spread
and lessen the likelihood of vascular uptake. A mixture of a lo-
cal anesthetic, lidocaine, and steroid, triamcinolone, or depo-
medrol, was injected without difficulty. During the LFJIs and
SIJIs, a 22-gauge 3.5-in spinal needle was advanced under AP,
lateral, and oblique fluoroscopy. When the needle tip was visu-
alized in the joint space, 0.5 mL of contrast was injected to con-
firm intra-articular and periarticular contrast spread and lessen
the likelihood of vascular uptake. A mixture of local anesthetic,
bupivacaine, and steroid, triamcinolone, or depo-medrol, was
injected without difficulty. All patients were then transferred
to the postprocedure care area and subsequently given standard
clinical care.TABLE 1. Characteristics of the Study Population (n = 136)
Age, y 54 (14)
Sex
Female 61.0% (n = 83)




55.0% (n = 75) [26.8 (61.3) mg]
Psychotropic drugs* 35.3% (n = 48)
Antiepileptic drugs
(for pain therapy)
41.5% (n = 56)
Duration of pain, mo 70 (78)
BPI pain score [0–10] 6.0 (1.7)
BPI interference score [0–10] 6.3 (2.3)
Roland-Morris score [0–24] 15.3 (5.2)
HADS-D [0–21] 7.4 (4.0)
HADS-A [0–21] 8.7 (4.3)
PCS [0–52] 23.1 (13.1)
Procedure
LESI 60.7% (n = 82)
LFJI 8.1% (n = 11)
SIJI 31.1% (n = 42)
Age, pain duration, morphine equivalents, and questionnaire scores
are given as mean (SD). For categorical variables, percentages and abso-
lute values are given.
*Antidepressants, neuroleptics, and benzodiazepines.
HADS-A, anxiety subscore; HADS-D, depression subscore.Statistical Analyses
A power analysis was conducted using GPower software
(version 3.1.2; Kiel, Germany) to determine the number of par-
ticipants included in the study. We assumed that the correlations
between PSQ scores and procedural pain ratings would be smal-
ler than those found with experimental pain testing (0.5–0.7)9,10
because of greater interindividual variability, due to larger group
inhomogeneity, different procedures used, and different physicians
carrying out these procedures. We therefore powered the study
to detect a correlation of Pearson r greater than or equal to
0.25 at P < 0.05 and with a power of 0.8, which implicates that
a sample size of 120 participants or more is needed. In the pres-
ent study, we recruited 136 participants.
Continuous variables were summarized using descriptive
statistics, giving mean (SD). Results of the psychological ques-
tionnaires and VAS ratings were treated as continuous variables
for the purpose of the present paper. Categorical variables (sex,
type of intervention, medication use) were reported as fre-
quency counts and percentages. Normality was tested using
the Kolmogorov-Smirnov test. Several parameters (PSQ minor
scores, RMQ scores, clinical pain duration, VAS 1 and VAS 2
scores) were not normally distributed because of significant
skewness in their distribution. Although the magnitude of para-
metric coefficients (eg, Pearson r) is robust against deviations
from normality, significance levels and confidence intervals
may be invalid for nonnormal distributions. On the other hand,
nonparametric tests give valid significance levels in the absence
of normality but the magnitude of coefficients (eg, Spearman ρ)
is difficult to interpret (eg, in terms of shared variance).33 We
therefore report parametric coefficients for correlations with
these parameters but verified significance levels by calculating
the corresponding nonparametric P value in every case. Pearson
r was used to test for correlations in all other cases. Bonferroni
adjustment was used to correct for multiple testing. Analysis
of variance was used to test for the influence of the type of
interventional pain procedure on pain ratings. Pearson r, linear510
Copyright © 2013 American Society of Regional Anesthesia and Painregression analysis, and analysis of variance were used to iden-
tify demographic and clinical predictors of procedural pain. For
all analyses, a P value of less than 0.05 was considered signifi-
cant. All statistical analyses were performed using SPSS Statis-
tics, version 18.0 (IBM; Somers, New York).RESULTS
A total of 136 patients were enrolled in this study. This
included a convenience sample of patients with low back pain
scheduled for a low back interventional procedure and patients
who passed the exclusion criteria. A flow diagram is presented
(Supplemental Digital Content 2, http://links.lww.com/AAP/A95).
The demographics and clinical characteristics of this sequen-
tial convenience sample are presented in Table 1.
Properties of the PSQ-E
Scores of the English PSQ (PSQ-E) are reported in Table 2.
There were no significant sex differences in PSQ-E scores.
There was a significant correlation between age and PSQ-E-
total (0.19, P < 0.05) and between age and PSQ-E-minor
(r = 0.20, P < 0.05; also significant using Spearman ρ; P < 0.05)
but not between age and PSQ-E-moderate. However, these cor-
relations did not survive Bonferroni correction.
Among the psychological cofactors, PSQ-E scores were
significantly correlated with pain catastrophizing (PCS scores)
but not with anxiety or depression (HADS scores, Table 3).
Among the clinical pain characteristics, PSQ-E scores were
significantly correlated with BPI pain scores, but correlations
with BPI interference scores, Roland-Morris scores or clinical
pain duration did not reach significance (Table 3).© 2013 American Society of Regional Anesthesia and Pain Medicine
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TABLE 2. PSQ-E Scores
Sex
Total Female Male
n 136 83 53
PSQ-E-total 4.2 (2.0) 4.3 (2.0) 4.0 (2.0)
PSQ-E-minor 3.2 (2.0) 3.3 (2.0) 2.9 (2.0)
PSQ-E-moderate 5.2 (2.1) 5.3 (2.2) 5.0 (2.0)
Values are mean (SD).
Scores were not significantly different in males and females.
TABLE 4. Correlations Between Procedural Pain Ratings and
Possible Predictors of Procedural Pain
Pain Rating
VAS 1* VAS 2*
n 133 131
PSQ PSQ-E-total 0.23† 0.33‡




Duration of pain, mo −0.03 −0.01
BPI pain score 0.16 0.25†
BPI interference score 0.14 0.27§






Total n = 136. Some patients did not give valid pain ratings at VAS 1
and VAS 2. Pain rating at VAS 3 was only introduced in the second half
of the study. Pearson r is given.
*Significance levels of correlations with PSQ-minor, VAS 1 and VAS
2 were confirmed using a nonparametric test (seen methods). Bonferroni
adjustment was not used because the purpose of the zero-order cor-





Regional Anesthesia and Pain Medicine • Volume 38, Number 6, November-December 2013 Validating the English PSQPrediction of Pain With Lidocaine Infiltration
Lidocaine infiltration pain ratings on the VAS (0–100)
were 23 (22) at VAS 1 (infiltration of lidocaine in dorsum of
hand for IV placement) and 35 (23) at VAS 2 (infiltration of
lidocaine in subcutaneous tissues at the initiation of the in-
terventional pain procedure). As pain ratings were not depen-
dent on the type of interventional pain procedure used (LESI,
LFJI, or SIJI), type of procedure was not included as a cofactor.
Age was not significantly correlated with lidocaine infiltration
pain at any time point and was also not included.
Parameters from 3 classes (PSQ-E scores, clinical pain cha-
racteristics, and psychological cofactors of pain) were tested
for prediction of lidocaine infiltration pain. In a first step, zero-
order correlations were calculated (Table 4). From each class,
the variable with the highest (significant or nonsignificant) zero-
order correlation to lidocaine infiltration pain was selected for
linear regression analysis. Only 1 variable from each class was
selected because of significant collinearity of parameters within
classes. For pain ratings at VAS 1, linear regression analysis
with stepwise selection of PSQ-E-minor, Roland-Morris score,
and PCS score as independent variables identified only PSQ-
E-minor as predictor (r = 0.26, P < 0.01, Fig. 1A). For pain
ratings at VAS 2, linear regression analysis with stepwise selec-
tion of PSQ-E-minor, BPI interference score, and PCS score as
independent variables identified PSQ-E-minor as the strongestTABLE 3. Correlations Between PSQ-E Scores, Psychological
Measures, and Clinical Pain Characteristics
PSQ-E-Total PSQ-E-Minor* PSQ-E-Moderate
HADS-D 0.05 0.05 0.03
HADS-A 0.14 0.13 0.12











n = 136. Pearson r is given.
*Significance levels of correlations with PSQ-minor were confirmed
using a nonparametric test (seen methods).
†P < 0.001.
‡P < 0.01.
§P < 0.05 after Bonferroni correction.
© 2013 American Society of Regional Anesthesia and Pain Medicine
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diction was significantly enhanced by further inclusion of BPI
interference score (model 2: βPSQ-E-minor = 0.31, P < 0.001;
βBPI interference score = 0.22, P < 0.01; total r = 0.40, P < 0.001,
Fig. 1B2).
We further tested if sex contributed to prediction of lido-
caine infiltration pain. However, there were no significant sex
differences in pain ratings at VAS 1 and VAS 2.DISCUSSION
The most important result of the present study was that it
demonstrated a correlation between the PSQ-E and clinically
relevant evoked pain ratings. Prediction of lidocaine infiltration
pain was further improved when information from the BPI was
added to the analysis. Hence, not only did this study validate the
PSQ-E as a measure of pain sensitivity equivalent to the original
German version (PSQ-G), but it also suggests that use of 2 brief
questionnaires (PSQ and BPI) should have clinical utility in
predicting those patients with high pain sensitivity. This predic-
tive value is important because it makes possible the identifica-
tion of high sensitivity before patients undergo a procedure,
influencing clinical decisions.
Specifically, the properties of PSQ-E scores obtained from
chronic back pain patients in the present study are similar to
those previously obtained in a group of mixed chronic pain
patients (n = 134) with the original German version.10 In the
German study, PSQ-G scores were 4.0 (1.7) (PSQ-G-total),
2.9 (1.5) (PSQ-G-minor), and 5.1 (2.0) (PSQ-G-moderate).10
These values are similar to those found with the PSQ-E in
the present study. In terms of psychological cofactors of pain
perception, the PSQ-E exhibits highest correlations with the511
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FIGURE 1. Correlations between pain ratings at VAS 1 and VAS 2 and predictors identified by linear regression. A, Pain rating at VAS 1. B,
Pain rating at VAS 2. Pearson r is given.
Sellers et al Regional Anesthesia and Pain Medicine • Volume 38, Number 6, November-December 2013pain-specific measure (PCS) and nonsignificant correlations with
measures of anxiety and depression (Table 3). These results are
comparable to those obtained with the PSQ-G, both in healthy
subjects9 and in chronic pain patients.10 These results also
support convergent validity (correlation with pain-specific mea-
sure) and divergent validity (no correlation with nonpain-
specific measure) of the PSQ-E.
Regarding the relation with clinical pain characteristics,
similar to previous results with the PSQ-G in chronic pain
patients,10 there was no correlation between PSQ-E and chronic
pain duration (Table 3). There was a significant correlation of
PSQ-E scores with BPI pain scores,10 similar to the correlation
between clinical pain intensity ratings and PSQ-G scores in the
German study (r = 0.18). Similar to previous studies using the
PSQ-G in healthy subjects9 and chronic pain patients,10 there
were no significant differences in PSQ-E scores between males
and females in the current study. Similar results have been
found for the PSQ-G, regarding correlations with results of ex-
perimental pain testing9 and for PSQ-G differences between
healthy subjects and chronic pain patients.10
In summary, both mean values and correlations with differ-
ent pain-related variables are very similar between PSQ-E and
PSQ-G in chronic pain patients, and PSQ-minor subscores seem
to be slightly superior to PSQ-total scores in both versions.
These results suggest that the English translation shares reliabi-
lity and validity with the original German version and that
results obtained with the PSQ-E are directly comparable to
those obtained with the PSQ-G.
Prediction of Lidocaine Infiltration
Pain by the PSQ-E
Pain during infiltration of local anesthetic in the hand or
back (VAS 1 and VAS 2, respectively) was predicted by PSQ-
E-minor scores with an r around 0.3. As the PSQ is a measure
of general pain perception, or “pain sensitivity,” results would
be expected to be similar to the prediction of procedural pain
by experimental pain testing. Although there are to the best of
our knowledge no reports attempting to predict pain during an
interventional procedure by experimental pain testing, greater
pain perception—when assessed preoperatively by advanced
experimental pain testing—has been associated with greater
persistent postoperative pain scores.6,34 Reported correlation
coefficients for the prediction of postoperative pain by experi-
mental pain testing have ranged between 0.1 and 0.5.35–39
Therefore, the prediction of lidocaine infiltration pain by the
PSQ in the present study is within the expected range.512
Copyright © 2013 American Society of Regional Anesthesia and PainPain during lidocaine infiltration in the back (VAS 2)
marked the greatest level of lidocaine infiltration pain collected
within the present study, and prediction of this parameter may,
therefore, be most relevant from a clinical perspective.Application of the PSQ for the
Pain Clinic Patient
Interindividual variability in pain perception is large, both
in healthy subjects and in chronic pain patients.10–12 Such diffe-
rences in pain sensitivity seem to influence pain experiences,
the development of chronic pain syndromes, and responses to
analgesic treatment.4,40 Unfortunately, chronic pain patients ex-
hibit a generalized enhancement of pain perception.7,41,42 The
overlap in pain perception between healthy subjects and chronic
pain patients is large so that strategies for identifying indi-
viduals with increased risk of sensitivity are needed. The pres-
ent results show that the PSQ-E may be used to identify those
patients.Limitations
The study has several limitations that may have affected
the correlation of the PSQ scores and procedural pain. Two
clinicians performed the standardized lidocaine injection. This
may have resulted in variability of this pain stimulus.
Another limitation relates to the low VAS 1 scores noted.
Some patients may have experienced little or no pain during
the pain stimulus of lidocaine infiltration if the means and stan-
dard deviations are considered; 47% of the patients had VAS 1
scores below or equal to 10 based on the results. This may have
helped to reveal low and high pain sensitivities. It was felt to be
meaningful to have the entire spectrum of responses because it
was reflective of patients’ responsiveness.
Combination of the PSQ with the BPI enhanced predictive
power of a patient’s lidocaine infiltration pain and sensitivity.
Although clinical lore would suggest a correlation between sen-
sitivity and a need for sedation, it will be up to the individual
clinician to determine value of this measure of sensitivity for
their practice. The typical pain clinician may prefer to only
use 1 measure for clinical utility as opposed to 2, which were
needed from the results of the study. This was done by Cohen
et al,32 who used the standardized subcutaneous local anesthetic
injection to predict response to epidural steroid injections. Use
of this measure with PSQ and BPI could potentially allow for
even greater predictive value in future studies.© 2013 American Society of Regional Anesthesia and Pain Medicine
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Regional Anesthesia and Pain Medicine • Volume 38, Number 6, November-December 2013 Validating the English PSQCONCLUSIONS
This study validated the English version of the PSQ, and,
if coupled with the BPI, it demonstrated utility in predicting
a patient’s pain with lidocaine infiltration. The PSQ offers ad-
vantages in a high-volume clinic setting because it can be
quickly administered and is noninvasive. Future studies may
assess test-retest reliability. In the present study, we only in-
cluded white patients for better comparability with the existing
German PSQ data, but ongoing studies are currently seeking to
determine the contributions that ethnicity may contribute to spe-
cific measures. Future research may also explore for correlations
in PSQ scores and other factors known to alter pain sensitivity
such as medication use.ACKNOWLEDGMENTS
The authors thank Theresa Hensley and Terry Byars for
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